Literature DB >> 28039360

Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.

Claudia Lentucci1, Anna C Belkina2,3, Carly T Cederquist1, Michelle Chan1, Holly E Johnson1, Sherry Prasad1, Amanda Lopacinski1, Barbara S Nikolajczyk3, Stefano Monti4, Jennifer Snyder-Cappione2,3, Bogdan Tanasa5, M Dafne Cardamone1, Valentina Perissi6.   

Abstract

Non-proteolytic ubiquitin signaling mediated by Lys63 ubiquitin chains plays a critical role in multiple pathways that are key to the development and activation of immune cells. Our previous work indicates that GPS2 (G-protein Pathway Suppressor 2) is a multifunctional protein regulating TNFα signaling and lipid metabolism in the adipose tissue through modulation of Lys63 ubiquitination events. However, the full extent of GPS2-mediated regulation of ubiquitination and the underlying molecular mechanisms are unknown. Here, we report that GPS2 is required for restricting the activation of TLR and BCR signaling pathways and the AKT/FOXO1 pathway in immune cells based on direct inhibition of Ubc13 enzymatic activity. Relevance of this regulatory strategy is confirmed in vivo by B cell-targeted deletion of GPS2, resulting in developmental defects at multiple stages of B cell differentiation. Together, these findings reveal that GPS2 genomic and non-genomic functions are critical for the development and cellular homeostasis of B cells.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Notch pathway; development; toll-like receptor (TLR); ubiquitin; ubiquitin-conjugating enzyme (E2 enzyme)

Mesh:

Substances:

Year:  2016        PMID: 28039360      PMCID: PMC5314172          DOI: 10.1074/jbc.M116.755132

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  111 in total

1.  Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65.

Authors:  H Jumaa; B Wollscheid; M Mitterer; J Wienands; M Reth; P J Nielsen
Journal:  Immunity       Date:  1999-11       Impact factor: 31.745

Review 2.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

3.  Naturally secreted immunoglobulins limit B1 and MZ B-cell numbers through a microbiota-independent mechanism.

Authors:  Andreia C Lino; Elodie Mohr; Jocelyne Demengeot
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113

Review 4.  Expanding role of ubiquitination in NF-κB signaling.

Authors:  Siqi Liu; Zhijian J Chen
Journal:  Cell Res       Date:  2010-12-07       Impact factor: 25.617

5.  B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.

Authors:  Yuanyuan Chu; J Christoph Vahl; Dilip Kumar; Klaus Heger; Arianna Bertossi; Edyta Wójtowicz; Valeria Soberon; Dominik Schenten; Brigitte Mack; Miriam Reutelshöfer; Rudi Beyaert; Kerstin Amann; Geert van Loo; Marc Schmidt-Supprian
Journal:  Blood       Date:  2010-11-18       Impact factor: 22.113

6.  TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Hiroyuki Tagawa; Shigeo Nakamura; Yasuo Morishima; Masao Seto
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

Review 7.  The evolving contribution of hematopoietic progenitor cells to lymphomagenesis.

Authors:  Oliver Weigert; David M Weinstock
Journal:  Blood       Date:  2012-08-06       Impact factor: 22.113

8.  Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming.

Authors:  Elena Maspero; Eleonora Valentini; Sara Mari; Valentina Cecatiello; Paolo Soffientini; Sebastiano Pasqualato; Simona Polo
Journal:  Nat Struct Mol Biol       Date:  2013-05-05       Impact factor: 15.369

9.  Human monocyte CD14 is upregulated by lipopolysaccharide.

Authors:  R Landmann; H P Knopf; S Link; S Sansano; R Schumann; W Zimmerli
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

10.  Structural basis for the RING-catalyzed synthesis of K63-linked ubiquitin chains.

Authors:  Emma Branigan; Anna Plechanovová; Ellis G Jaffray; James H Naismith; Ronald T Hay
Journal:  Nat Struct Mol Biol       Date:  2015-07-06       Impact factor: 15.369

View more
  10 in total

1.  Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response.

Authors:  Angela C Court; Alice Le-Gatt; Patricia Luz-Crawford; Eliseo Parra; Victor Aliaga-Tobar; Luis Federico Bátiz; Rafael A Contreras; María Ignacia Ortúzar; Mónica Kurte; Roberto Elizondo-Vega; Vinicius Maracaja-Coutinho; Karina Pino-Lagos; Fernando E Figueroa; Maroun Khoury
Journal:  EMBO Rep       Date:  2020-01-27       Impact factor: 8.807

2.  Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation.

Authors:  Maria Dafne Cardamone; Bogdan Tanasa; Carly T Cederquist; Jiawen Huang; Kiana Mahdaviani; Wenbo Li; Michael G Rosenfeld; Marc Liesa; Valentina Perissi
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

3.  A master erythroid regulator gets its own GPS.

Authors:  Lily Jun-Shen Huang; James J Bieker
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

Review 4.  The Mitochondrial Unfolded Protein Response as a Non-Oncogene Addiction to Support Adaptation to Stress during Transformation in Cancer and Beyond.

Authors:  Timothy C Kenny; Giovanni Manfredi; Doris Germain
Journal:  Front Oncol       Date:  2017-07-26       Impact factor: 6.244

5.  Loss of G-Protein Pathway Suppressor 2 Promotes Tumor Growth Through Activation of AKT Signaling.

Authors:  Stefanie Chan; Emma Smith; Yuan Gao; Julian Kwan; Benjamin C Blum; Andrew M Tilston-Lunel; Isabella Turcinovic; Xaralabos Varelas; Maria Dafne Cardamone; Stefano Monti; Andrew Emili; Valentina Perissi
Journal:  Front Cell Dev Biol       Date:  2021-01-07

Review 6.  The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy.

Authors:  Xiaodi Du; Hongyu Song; Nengxing Shen; Ruiqi Hua; Guangyou Yang
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

7.  Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly.

Authors:  Wenxiao Gong; Xinglin He; Kun Huang; Yufei Zhang; Chengfei Li; Ying Yang; Zhong Zou; Meilin Jin
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

Review 8.  Non-proteolytic ubiquitylation in cellular signaling and human disease.

Authors:  Yongrong Liao; Izabela Sumara; Evanthia Pangou
Journal:  Commun Biol       Date:  2022-02-08

9.  G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor.

Authors:  Yuan Si; Haitao Zhang; Peng Peng; Chu Zhu; Jie Shen; Yilian Xiong; Xuewen Liu; Yuchen Xiang; Wenjuan Li; Yuliang Ren; Fang Wan; Liang Zhang; Ying Liu
Journal:  Cancer Sci       Date:  2021-10-20       Impact factor: 6.716

10.  Leishmania differentiation requires ubiquitin conjugation mediated by a UBC2-UEV1 E2 complex.

Authors:  Rebecca J Burge; Andreas Damianou; Anthony J Wilkinson; Boris Rodenko; Jeremy C Mottram
Journal:  PLoS Pathog       Date:  2020-10-27       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.